Market Overview

Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin

Share:
Related HITK
Hi-Tech Pharmacal Receives FDA Final Approval for Bromfenac Ophthalmic Solution, 0.09%
US Stock Futures Up; Jobless Claims Data In Focus
Related AKRX
Benzinga's Top Initiations
Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks
Goldman bearish on Akorn, starts coverage with Sell rating; shares off 5% (Seeking Alpha)

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Hi Tech Pharmacal Co (NASDAQ: HITK) is 15.77%. Hi Tech Pharmacal's ROE for the same period is 15.20%.

The trailing-twelve-month profit margin at Akorn (NASDAQ: AKRX) is 13.81%. Akorn had $40.78 million in total cash for the latest quarter.

The trailing-twelve-month profit margin at Mylan (NASDAQ: MYL) is 9.43%. Mylan's revenue for the same period is $6.80 billion.

The trailing-twelve-month profit margin at Salix Pharmaceuticals (NASDAQ: SLXP) is 8.74%. Salix's ROA for the same period is 7.24%.

Posted-In: Drugs-Generic Industry Highest Profit MarginTrading Ideas

 

Related Articles (AKRX + HITK)

View Comments and Join the Discussion!